This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Ellipses Pharma Limited, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chengxi Yang: Innovator in Pyrimidine Compounds
Introduction
Chengxi Yang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on pyrimidine compounds. His expertise and dedication to research have led to the development of valuable patents that enhance the understanding and application of these compounds.
Latest Patents
Chengxi Yang holds a patent for a "Salt and crystal form of pyrimidine compound, and preparation methods therefor." This patent provides a detailed description of a salt and a crystal form of a pyrimidine compound, including preparation methods. The innovation focuses on the specific characteristics of the compound, which can be crucial for various applications in the pharmaceutical industry. He has 1 patent to his name.
Career Highlights
Throughout his career, Chengxi Yang has worked with prominent companies in the biopharmaceutical sector. Notably, he has been associated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. and Ellipses Pharma Limited. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Chengxi Yang has collaborated with esteemed colleagues, including Zheng Gong and Hongming Li. These partnerships have fostered a productive environment for innovation and have led to advancements in the understanding of pyrimidine compounds.
Conclusion
Chengxi Yang's contributions to the field of biopharmaceuticals, particularly through his patent on pyrimidine compounds, highlight his role as an innovator. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile